FDA seeks outside review of Ketek antibiotic on December 14 and 15
The antibiotic Ketek, is under scrutiny amid reports of liver failure in a dozen patients. Ketek, approved in 2004, is also the subject of a Senate Finance Committee investigation because of the FDA's handling of the approval and of possibly faulty data.